Wdol-SP Tablet is a combination analgesic formulation containing Aceclofenac 100 mg, Paracetamol 325 mg, and Serratiopeptidase 15 mg, designed to provide effective relief from pain and inflammation. Aceclofenac, a non-steroidal anti-inflammatory drug (NSAID), exerts its action by inhibiting cyclooxygenase enzymes, thereby reducing the synthesis of prostaglandins responsible for pain and inflammation. Paracetamol acts centrally to alleviate pain and reduce fever through inhibition of the prostaglandin synthesis pathway in the central nervous system. Serratiopeptidase, a proteolytic enzyme, facilitates the breakdown of inflammatory mediators and promotes the resolution of edema and tissue inflammation. This synergistic combination is indicated for the management of musculoskeletal disorders such as osteoarthritis, rheumatoid arthritis, ankylosing spondylitis, and soft tissue injuries including sprains, strains, and post-operative inflammation. Wdol-SP Tablet offers rapid onset of analgesia along with sustained anti-inflammatory effects, improving patient comfort and mobility. It should be used under medical supervision, considering contraindications such as hypersensitivity to NSAIDs, active peptic ulcer, or bleeding disorders. Caution is advised in patients with hepatic, renal, or cardiovascular impairment. The tablet is typically administered orally, with dosage and duration tailored according to clinical response and physician guidance.